spacer
spacer

PDBsum entry 2nqd

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase inhibitor/hydrolase PDB id
2nqd

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
109 a.a. *
221 a.a. *
Ligands
NAG-NAG
Metals
_NA
_CL
Waters ×564
* Residue conservation analysis
PDB id:
2nqd
Name: Hydrolase inhibitor/hydrolase
Title: Crystal structure of cysteine protease inhibitor, chagasin, in complex with human cathepsin l
Structure: Chagasin. Chain: a. Synonym: cysteine protease inhibitor. Engineered: yes. Cathepsin l. Chain: b. Fragment: residues 1-220. Synonym: cysteine protease, major excreted protein, mep. Engineered: yes.
Source: Trypanosoma cruzi. Organism_taxid: 5693. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Homo sapiens. Human. Organism_taxid: 9606. Expressed in: pichia pastoris. Expression_system_taxid: 4922.
Resolution:
1.75Å     R-factor:   0.150     R-free:   0.188
Authors: I.Redzynia,G.Bujacz,A.Ljunggren,M.Jaskolski,M.Abrahamson
Key ref:
A.Ljunggren et al. (2007). Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease. J Mol Biol, 371, 137-153. PubMed id: 17561110 DOI: 10.1016/j.jmb.2007.05.005
Date:
31-Oct-06     Release date:   24-Jul-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q966X9  (CHAG_TRYCR) -  Chagasin from Trypanosoma cruzi
Seq:
Struc:
110 a.a.
109 a.a.
Protein chain
Pfam   ArchSchema ?
P07711  (CATL1_HUMAN) -  Procathepsin L from Homo sapiens
Seq:
Struc:
333 a.a.
221 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chain B: E.C.3.4.22.15  - cathepsin L.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specificity close to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity towards protein substrates, but has little activity on Z-Arg-Arg-NHMec, and no peptidyl-dipeptidase activity.

 

 
DOI no: 10.1016/j.jmb.2007.05.005 J Mol Biol 371:137-153 (2007)
PubMed id: 17561110  
 
 
Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
A.Ljunggren, I.Redzynia, M.Alvarez-Fernandez, M.Abrahamson, J.S.Mort, J.C.Krupa, M.Jaskolski, G.Bujacz.
 
  ABSTRACT  
 
Chagasin is a protein produced by Trypanosoma cruzi, the parasite that causes Chagas' disease. This small protein belongs to a recently defined family of cysteine protease inhibitors. Although resembling well-known inhibitors like the cystatins in size (110 amino acid residues) and function (they all inhibit papain-like (C1 family) proteases), it has a unique amino acid sequence and structure. We have crystallized and solved the structure of chagasin in complex with the host cysteine protease, cathepsin L, at 1.75 A resolution. An inhibitory wedge composed of three loops (L2, L4, and L6) forms a number of contacts responsible for high-affinity binding (K(i), 39 pM) to the enzyme. All three loops interact with the catalytic groove, with the central loop L2 inserted directly into the catalytic center. Loops L4 and L6 embrace the enzyme molecule from both sides and exhibit distinctly different patterns of protein-protein recognition. Comparison with a 1.7 A structure of uncomplexed chagasin, also determined in this study, demonstrates that a conformational change of the first binding loop (L4) allows extended binding to the non-primed substrate pockets of the enzyme active site cleft, thereby providing a substantial part of the inhibitory surface. The mode of chagasin binding is generally similar, albeit distinctly different in detail, when compared to those displayed by cystatins and the cysteine protease inhibitory p41 fragment of the invariant chain. The chagasin-cathepsin L complex structure provides details of how the parasite protein inhibits a host enzyme of possible importance in host defense. The high level of structural and functional similarity between cathepsin L and the T. cruzi enzyme cruzipain gives clues to how the cysteine protease activity of the parasite can be targeted. This information will aid in the development of synthetic inhibitors for use as potential drugs for the treatment of Chagas disease.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. Structure of the chagasin-cathepsin L complex. (a) A ribbon stereodiagram of the complex. The inhibitor molecule is colored gold and the enzyme blue. The surfaces of both proteins are marked in an analogous way. The view corresponds to the standard orientation used for cysteine proteases, along the interface between the left (L) and right (R) domains forming the sides of the active site cleft of cathepsin L. (b) Interaction of chagasin in the catalytic cleft of cathepsin L, viewed perpendicular to the standard orientation, with the L-domain behind the inhibitor molecule and the R-domain in the front. The side-chains of residues crucial for enzyme interactions are represented by sticks and balls (the disordered side-chain of K63 is shown in both alternative conformations) The enzyme is colored blue and the framework inhibitor molecule gold, with the enzyme-interacting loops L4, L2 and L6 in light yellow, orange and gold, respectively. (c)–(e) Details of the enzyme interactions of loops (c) L2, (d) L4 and (e) L6. In (c), side-chains of the interacting residues are shown in 2F[o]–F[c] electron density contoured at the 1.2ó level, to illustrate its quality.
Figure 5.
Figure 5. Superposition of chagasin with the active site of cruzipain. (a) A ribbon stereo diagram of the superposition of the chagasin–cathepsin L complex (colored as in Figure 3(a)) with cruzipain (burgundy), after least-squares fit of the C^α traces of the enzymes. The view is in the standard orientation along the active site cleft of the enzymes. (b) A detailed view of the interactions showing the central part of the chagasin inhibitory wedge (with the L4 loop light yellow and the L2 loop orange) and the complementary fragment of the L-domain of cruzipain (burgundy). The side-chains of residues crucial for the interactions are shown in ball-and-stick representation. The synthetic inhibitor P10 ([(1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester), from the complex with cruzipain (PDB code 1ME3) is shown in green.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2007, 371, 137-153) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  21326229 M.A.Adams-Cioaba, J.C.Krupa, C.Xu, J.S.Mort, and J.Min (2011).
Structural basis for the recognition and cleavage of histone H3 by cathepsin L.
  Nat Commun, 2, 197.
PDB codes: 3iv2 3k24
19846555 M.Renko, J.Sabotic, M.Mihelic, J.Brzin, J.Kos, and D.Turk (2010).
Versatile loops in mycocypins inhibit three protease families.
  J Biol Chem, 285, 308-316.
PDB codes: 3h6q 3h6r 3h6s
20860624 M.Renko, U.Požgan, D.Majera, and D.Turk (2010).
Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft.
  FEBS J, 277, 4338-4345.
PDB code: 3k9m
20175878 R.Kolodziejczyk, K.Michalska, A.Hernandez-Santoyo, M.Wahlbom, A.Grubb, and M.Jaskolski (2010).
Crystal structure of human cystatin C stabilized against amyloid formation.
  FEBS J, 277, 1726-1737.
PDB code: 3gax
20012364 V.Heussler, A.Rennenberg, and R.Stanway (2010).
Host cell death induced by the egress of intracellular Plasmodium parasites.
  Apoptosis, 15, 376-385.  
19596863 E.T.Larson, F.Parussini, M.H.Huynh, J.D.Giebel, A.M.Kelley, L.Zhang, M.Bogyo, E.A.Merritt, and V.B.Carruthers (2009).
Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl.
  J Biol Chem, 284, 26839-26850.
PDB code: 3f75
19143838 I.Redzynia, A.Ljunggren, A.Bujacz, M.Abrahamson, M.Jaskolski, and G.Bujacz (2009).
Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
  FEBS J, 276, 793-806.
PDB code: 3e1z
19729072 R.C.Goldenberg, D.A.Iacobas, S.Iacobas, L.L.Rocha, F.da Silva de Azevedo Fortes, L.Vairo, F.Nagajyothi, A.C.Campos de Carvalho, H.B.Tanowitz, and D.C.Spray (2009).
Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes.
  Microbes Infect, 11, 1140-1149.  
19111576 R.Huang, X.Que, K.Hirata, L.S.Brinen, J.H.Lee, E.Hansell, J.Engel, M.Sajid, and S.Reed (2009).
The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin.
  Mol Biochem Parasitol, 164, 86-94.  
18201565 F.C.dos Reis, B.O.Smith, C.C.Santos, T.F.Costa, J.Scharfstein, G.H.Coombs, J.C.Mottram, and A.P.Lima (2008).
The role of conserved residues of chagasin in the inhibition of cysteine peptidases.
  FEBS Lett, 582, 485-490.  
18515357 I.Redzynia, A.Ljunggren, M.Abrahamson, J.S.Mort, J.C.Krupa, M.Jaskolski, and G.Bujacz (2008).
Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B.
  J Biol Chem, 283, 22815-22825.
PDB codes: 3cbj 3cbk
18979626 J.Scharfstein, A.C.Monteiro, V.Schmitz, and E.Svensjö (2008).
Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway.
  Biol Chem, 389, 1015-1024.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer